Aclarion Net Income

ACON Stock  USD 2.75  0.39  16.53%   
As of the 7th of February, Aclarion shows the Mean Deviation of 5.45, risk adjusted performance of (0.09), and Standard Deviation of 9.27. Aclarion technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Aclarion Total Revenue

58,192.39

Aclarion's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Aclarion's valuation are provided below:
Gross Profit
-16.6 K
Market Capitalization
3.6 M
Enterprise Value Revenue
31.011
Revenue
62.9 K
Earnings Share
(12.12)
We have found one hundred twenty available fundamental signals for Aclarion, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Aclarion's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 7th of February 2026, Market Cap is likely to drop to about 134.2 K. In addition to that, Enterprise Value is likely to grow to about (361.5 K) This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Loss-6.3 M-6.6 M
Net Loss-6.7 M-7.1 M
Net Loss-6.3 M-6.6 M
Net Loss-6.7 K-7 K
As of the 7th of February 2026, Net Loss is likely to drop to about (6.6 M). In addition to that, Net Loss is likely to drop to about (7.1 M).
  
Build AI portfolio with Aclarion Stock
Evaluating Aclarion's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aclarion's fundamental strength.

Latest Aclarion's Net Income Growth Pattern

Below is the plot of the Net Income of Aclarion over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Aclarion financial statement analysis. It represents the amount of money remaining after all of Aclarion operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Aclarion's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aclarion's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (6.99 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Aclarion Net Income Regression Statistics

Arithmetic Mean(4,803,115)
Coefficient Of Variation(24.20)
Mean Deviation941,934
Median(4,019,258)
Standard Deviation1,162,270
Sample Variance1.4T
Range3M
R-Value(0.80)
Mean Square Error517.9B
R-Squared0.64
Significance0.0001
Slope(184,211)
Total Sum of Squares21.6T

Aclarion Net Income History

2026-6.6 M
2025-6.3 M
2024-7 M
2023-4.9 M
2022-7.1 M
2021-5 M
2020-4.6 M

Other Fundumenentals of Aclarion

Aclarion Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Aclarion is extremely important. It helps to project a fair market value of Aclarion Stock properly, considering its historical fundamentals such as Net Income. Since Aclarion's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aclarion's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aclarion's interrelated accounts and indicators.
Will Health Care Equipment & Supplies sector continue expanding? Could Aclarion diversify its offerings? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aclarion data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(12.12)
Revenue Per Share
0.108
Quarterly Revenue Growth
0.761
Return On Assets
(0.44)
Return On Equity
(0.88)
Investors evaluate Aclarion using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Aclarion's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Aclarion's market price to deviate significantly from intrinsic value.
Understanding that Aclarion's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aclarion represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Aclarion's market price signifies the transaction level at which participants voluntarily complete trades.

Aclarion 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aclarion's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aclarion.
0.00
11/09/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/07/2026
0.00
If you would invest  0.00  in Aclarion on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Aclarion or generate 0.0% return on investment in Aclarion over 90 days. Aclarion is related to or competes with Bullfrog, Kazia Therapeutics, Soligenix, Silo Pharma, Can Fite, Clearmind Medicine, and Applied DNA. Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy in th... More

Aclarion Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aclarion's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aclarion upside and downside potential and time the market with a certain degree of confidence.

Aclarion Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Aclarion's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aclarion's standard deviation. In reality, there are many statistical measures that can use Aclarion historical prices to predict the future Aclarion's volatility.
Hype
Prediction
LowEstimatedHigh
0.142.8812.51
Details
Intrinsic
Valuation
LowRealHigh
0.387.5417.17
Details
Naive
Forecast
LowNextHigh
0.042.2111.85
Details
1 Analysts
Consensus
LowTargetHigh
20.0222.0024.42
Details

Aclarion February 7, 2026 Technical Indicators

Aclarion Backtested Returns

Aclarion secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11 % return per unit of risk over the last 3 months. Aclarion exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aclarion's Standard Deviation of 9.27, risk adjusted performance of (0.09), and Mean Deviation of 5.45 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.58, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aclarion will likely underperform. At this point, Aclarion has a negative expected return of -1.1%. Please make sure to confirm Aclarion's maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Aclarion performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.10  

Insignificant predictability

Aclarion has insignificant predictability. Overlapping area represents the amount of predictability between Aclarion time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aclarion price movement. The serial correlation of 0.1 indicates that less than 10.0% of current Aclarion price fluctuation can be explain by its past prices.
Correlation Coefficient0.1
Spearman Rank Test-0.05
Residual Average0.0
Price Variance1.35
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Aclarion reported net income of (6.99 Million). This is 102.05% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 101.22% higher than that of the company.

Aclarion Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aclarion's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aclarion could also be used in its relative valuation, which is a method of valuing Aclarion by comparing valuation metrics of similar companies.
Aclarion is currently under evaluation in net income category among its peers.

Aclarion Current Valuation Drivers

We derive many important indicators used in calculating different scores of Aclarion from analyzing Aclarion's financial statements. These drivers represent accounts that assess Aclarion's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aclarion's important valuation drivers and their relationship over time.
202120222023202420252026 (projected)
Enterprise Value21.1M2.1M1.9M(330.9K)(380.5K)(361.5K)

Aclarion ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Aclarion's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aclarion's managers, analysts, and investors.
Environmental
Governance
Social

Aclarion Institutional Holders

Institutional Holdings refers to the ownership stake in Aclarion that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Aclarion's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aclarion's value.
Shares
Ubs Group Ag2025-06-30
1.7 K
Tower Research Capital Llc2025-06-30
75.0
Bank Of America Corp2025-06-30
8.0
Clear Street Llc.2025-06-30
3.0
Morgan Stanley - Brokerage Accounts2025-06-30
0.0

Aclarion Fundamentals

About Aclarion Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Aclarion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aclarion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aclarion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Aclarion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aclarion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aclarion Stock

  0.67OTC Ocumetics Technology CorpPairCorr
  0.67AHC Austco HealthcarePairCorr

Moving against Aclarion Stock

  0.77VMD Viemed HealthcarePairCorr
  0.69QIPT Quipt Home Medical Earnings Call This WeekPairCorr
  0.654DX 4DMEDICALPairCorr
  0.44AMS Advanced Medical SolPairCorr
  0.44TRLS Trellus Health plcPairCorr
The ability to find closely correlated positions to Aclarion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aclarion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aclarion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aclarion to buy it.
The correlation of Aclarion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aclarion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aclarion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aclarion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports:
Check out
To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Health Care Equipment & Supplies sector continue expanding? Could Aclarion diversify its offerings? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aclarion data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(12.12)
Revenue Per Share
0.108
Quarterly Revenue Growth
0.761
Return On Assets
(0.44)
Return On Equity
(0.88)
Investors evaluate Aclarion using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Aclarion's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Aclarion's market price to deviate significantly from intrinsic value.
Understanding that Aclarion's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aclarion represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Aclarion's market price signifies the transaction level at which participants voluntarily complete trades.